otein in neutrophilic leukocytes, J. Exp. Med., 130, 643—658 (1969).

68. Leffell M.S. Spitznagel J.K. Association of lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes, Infect. Immunol., 6, 761—765 (1972).

69. BorosD.L. Hypersensitivity granulomas. In: Allergy: Principles and Practice, ed. by E. Mid-dleton, C.E. Reed and E.F. Ellis, pp. 101—114, C.V. Mosby, St. Louis, 1978.

70. Hocking W.G., Golde D.W. The pulmonary-alveolar macrophage, N. Engl. J. Med., 301, 580—587 (1979).

71. Nathan C.F., Murray H.W., Cohn Z. Current concepts: The macrophage as an effector cell, N. Engl. J. Med., 303, 622-626 (1980).

72. Golde D.W., Hocking W.G. Monocyte and macrophage development. In: Advances in Host Defence Mechanism, V. 1, ed. by J.I. Gallin and A.S. Fauci, pp. 13—30, Raven Press, New York, 1982.

73. Griffin F.M., Jr. Mononuclear cell phagocytic mechanisms and host defence. In: Advances in Host Defence Mechanism, ed. by J.I. Gallin and A.S. Fauci, pp. 31—55, Raven Press, New York, 1982.

74. Edelston P.C, Monocytes and macrophages: Aspects of their cell biology. In: Cell Biology of Inflammation, ed. by G. Weissmann, pp. 469—496, Elsevier/North-Holland, New York, 1980.

75. Henson M., Ginsberg M.H., Morrison D.G. Mechanism of mediator response by inflammatory cells. In: Membrane Fusion, ed. by G. Poste and G.L. Nicolson, pp. 411—509, Elsevier/ North-Holland Biomedical Press, New York, 1978.

76. Nakagawara A., Nathan C.F., Cohn Z.A. Hydrogen peroxide metabolism in human monocytes during differentiation in vitro, J. Clin. Invest., 68, 1243—1252 (1981).

77. Rabinovitch M. Phagocytic recognition. In: Mononuclear Phagocytes ed. by R. Van Furth, p. 299—313, Blackwell Scientific Publications, Oxford, 1970.

78. Kurlander R.J., Batker J. The binding of human immunoglobulin GI monomer and small covalently cross-linked polymers of immunoglobulin GI to human peripheral blood monocytes and polymorphonuclear leukocytes, J. Clin. Invest., 69, 1—8 (1982).

79. Dower S.K., DeLisi C, Titus J.A., Segal D.M. Mechanism of binding of multivalent immune complexes to Fc receptors. I. Equilibrium binding, Biochemistry, 20, 6326—6334 (1981).

80. Phillips-Quagliata J.M., Levine B.B., Quagliata F., Uhr J.W. Mechanism underlying binding of immune complexes to macrophages, J. Exp. Med., 133, 589—601 (1971).

81. Arend W.P., Mannik M. The macrophage receptor for IgG: Number and affinity of binding sites, J. Immunol., 110, 1455—1463 (1973). Ч. В. Паркер

82. Unkeless J.C., Eisen H.N. Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages, J. Exp. Med., 142, 1520—1533 (1975).

83. Anderson C.L., Abraham G.M. Characterization of the Fc receptor for IgG on a human macrophage cell line, U937, J. Immunology, 125, 2735—2741 (1980).

84. Dower S.K., DeLisi C. Titus J.A. Segal D.M. Mechanism of binding of multivalent immune^ complexes to Fc receptors. II. Kinetics of binding, Biochemistry, 20, 6335—6340

85. Barnett Foster D.E., Dorrington K.J., Painter R.H. Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgGi for binding to the Fc receptor of human monocytes, J. Immunol., 124, 2186—2190 (1980).

86. Lane B.C., Cooper S.M. Fc receptors of mouse cell lines I. Distinct proteins mediate the IgG subclass-specific Fc binding activities of macrophages, J. Immunol., 128, 1819—1824 (1982). '

87. Lane B.C., Кап-Mitchell J., Mitchell M.S., Cooper S.M. Structural evidence for distince IgG subclass-specific Fc receptors on mouse peritoneal macrophages, J.Exp. Med., 152, 1147-1161 (1980).

88. Diamond В., Yelton D.E. A new Fc receptor on mouse macrophages binding IgG3, J. Exp. Med., 153, 514-519 (1981).

89. Boltz-Nitulescu G. Plummer J.M., Spielberg H.L. Fc receptors for IgE on mouse macrophages and macrophage-like cell lines, J. Immunol., 128, 2265—2268 (1982).

90. Anderson C.L., Spielberg H.L. Macrophage receptors for IgE: Binding of IgE to specific IgE Fc receptors on a human macrophage cell line U937, J. Immunol., 126, 2470—2473 (1981).

91. С apron A., Dessaint J.-P. J osef M., Rousseaux R. С apron M. Bazin H. Interaction between IgE complexes and macrophages in the rat: A new mechanism of macrophage activation, Eur. J. Immunol., 7, 315—322 (1977).

92. Gisler R.H., Fridman W.H. Supression in vitro antibody syntesis by immunoglobulin binding factor, J. Exp. Med., 142, 507—511 (1975).

93. Bich-Thuy L.T., Samarut C, Brochier J., Revillard J.-P. Supression of the alter stages of mitogen-induced human В cell differentiation by Fc у receptors (Fc yR) released from polymorphonuclear neutrophils, J. Immunol., 127, 1299—1303 (1981).

94. Kulczycki A. Jr., Krause V., Chew-Killion C, Atkinson J.P. Purification of Fc receptor from rabbit alveolar macrophages that retains ligand-binding activity, J. Immunol., 124, 2772—2779 (1980).

95. Dixit R., Schneider R., Law S.K., Kulczycki A.K., Jr., Atkinson J.P. Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b, J. Biol. Chem. 257, 1595—1597 (1981).

96. Kulczycki A.K., Jr., Parker C.W. The cell surface receptor for immunoglobulin E. I. The use of repetitive affinity chromatography for the purification of a mammalian receptor, J. Biol. Chem., 254, 3187—3193 (1979).

97. Hoover R.G., Dieckgraefe B.K., Lynch R.G. T cells with Fc receptors for IgA: Induction of Ta cells in vivo and in vitro by purified IgA, J. Immunol., 127, 1560—1563 (1981).

98. Yodoi J., Ishizaka K. Induction of the Fc -receptor bearing cells in vitro in human peripheral lymphocytes, J. Immunol., 124 , 934 —938 (1980).

99. Hoover R.G., Hickman S., Gebel H.M., Rebbe N., Lynch R.G. Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma, J. Clin. Invest., 67, 308—311 (1981).

100. Gonzalez-Molina A., Spielberg H.L. A subpopulation of normal human peripheral В lymphocytes that bind IgE, J. Clin. Invest., 59, 616—624 (1977).

101. Spiegelberg H.L., O'Connor R.D., Simon R.A., Mathison D.A. Lymphocytes with immunoglobulin E Fc receptors in patients with atopic disorders, J. Clin. Invest., 64, 714—720 (1979).

102. Spiegelberg H. L., Simon R.A. Increase of lymphocytes with Fc receptors for IgE inpatients with allergic rhinitis during the grass pollen season, J. Clin. Invest., 68, 845—852 (1981).

103. Melewica P.M., Zeiger R.S., Mellon M.H., O'Connor R.D., Spiegelberg H.L. Increased peripheral blood monocytes with Fc receptors for IgE in patients with severe allergic disorders, J. Immunol., 126, 1592—1595 (1981).

104. Malveaux F.J., Conroy M.C., Adkinson N.F., Lichtenstein L.M. IgE receptors on human basophils: Relationship to serum IgE concentrations, J. Clin. Invest., 62, 176—181 (1978).

105. Kahn C.R., Flier J.S. Immunologic aspects of endocrine disease. In: Clinical Immunology, ed. by C.W. Parker, pp. 815—866, W. B. Saunders, Philadelphia, 1980.

106. Burchiel S.W., Warner N.L. Cyclic AMP modulation of Fc receptor expression on a pre-B cell lymphoma, J. Immunol., 124, 1016—1021 (1980).

27. Медиаторы: высвобождение и функции 235

107. Rhodes J. Modulation of neacrophade Fc receptor expresion in vitro by insulin and cyclic nucleotides, Nature, 257, 597—599 (1975).

108. Hempstead B.L., Parker C.W., Kulczycki A., Jr. Selective phosphorylation of the IgE receptor in antigen stimulated rat mast cells, J. Exp. Med. (in press), (1983).

109. Suzuki Т., Saito-Taki Т., Sadasivan R., Nitta T. Biochemical signal transmitted by Fey receptors: Phospholipase A2 activity of Fcy2b receptor of murine macrophage cell line P388DJ, Proc. Natl. Acad. Sci. USA, 79, 591—595 (1982).

110. Nitta Т., Suzuki T. Fcy24 receptor-mediated prostaglandin synthesis by a murine macrophage cell line (388D!), J. Immunol., 128, 2527—2532 (1982).

110a.Hempstead В., Kulczycki A., Parker C.W. Personal communication.

111. Griffin P.M., Jr, Griffin J .A. Augmentation of macrophage complement receptor function in vitro, J. Immunol., 125, 844—849 (1980).

112. Alper C.A., Rosen P.S. Genetics of the complement system, Adv. Hum. Genet., 7, 141 — 188 (1976).

113. Ooi Y.M., Harris D.E., Edelson P.J., Colten H.R. Post-translational control of complement (C5) production by resident and stimulated mouse macrophages, J. Immunol., 124, 2077—2081 (1980).

114. Ooi Y.M. Histamine supresses in vitro synthesis of precursor (PRO—C5) of the fifth compliment component (C5) by mouse peritoneal macrophages, J. Immunol., 129, 200—205 (1982).

115. Ralph P. Continuous macrophage cell lines: Their use in the study of induced and constitutive macrophage properties and cytotoxicity, In: Lymphokines, ed. by E. Pick, pp. 175 — 196, Academic Press, New York, 1981.

116. Rocklin R.E., Bendtzen K., Greineder D. Mediators of immunity: Lymphokines and monokines, Adv. Immunol., 29, 55—136 (1980).

117. Stadeker M.J., Wyler D.JWright J. Ia antigen expression and antigen presenting function by macrophages isolated from hypersensitivity granulomas, J. Immunol., 128, 2739—2744 (1982).

118. Murphy P.A., Simon P.L., Willoughby W.F. Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages, J. Immunol., 124, 2498—2501 (1980).

119. Schmidt J.A., Mizel S.B., Cohen D., Green I. Interleukin 1, a potential regulator of fibroblast proliferation, J. Immunol. 128, 2177—2182 (1982).

120. Glenn K.C., Ross R. Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A, Cell, 25, 605—615 (1981).

121. Dinarello CA. Human pyrogen: A monocyte product mediating host defenses. In: Advances in Host Defense Mechanisms, V. 1, ed. by J.I. Gallin and A.S. Fauci, pp. 57—74, Raven Press, New York, 1982.

122. Gospodarowicz D. Growth factors for animal cells i